论文部分内容阅读
探讨1979年1月～1985年7月52例多发性骨髓瘤(MM)患者[ⅢA+ⅢB48例(92%)],用CCPV或M_2方案治疗。结果:平均生存期分别为82.6±5.7月和6.3±2.8月(P<0.001)。用卡方或精确概率法检验存活>5年
52 patients with multiple myeloma (MM) [ⅢA + ⅢB48 (92%)] from January 1979 to July 1985 were treated with CCPV or M 2 regimen. Results: The average survival was 82.6 ± 5.7 months and 6.3 ± 2.8 months (P <0.001). Survival of> 5 years with chi-square or exact probabilistic test